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Introduction {#sec1}
============

Since the breakthrough discovery of transcription factor (TF)-driven reprogramming by Shinya Yamanaka ([@bib74]), multiple studies have addressed the function of each component of the reprogramming cocktail ([@bib36], [@bib41], [@bib67], [@bib68], [@bib80]). Subsequent work from Yamanaka's laboratory showed that, of the four TFs in the reprogramming cocktail---Oct4, Sox2, Klf4, and cMyc (OSKM)---only cMyc could be omitted while still permitting generation of induced pluripotent stem cells (iPSCs) ([@bib47]). Moreover, although Sox2, Kfl4, and cMyc could be replaced by other members of their TF families, Oct4 could not be substituted by either Oct1 or Oct6. Numerous attempts have been made to replace the components of the reprogramming cocktail to understand the molecular role of each factor, as well as potentially improve efficiency and safety of the reprogramming technology ([@bib56]).

Although many studies have shown the possibility of substitutions for Oct4 in the reprogramming cocktail ([Table S1](#mmc1){ref-type="supplementary-material"}), Oct4 remains a commonly used molecule for generating iPSCs. In fact, we and others have demonstrated that exogenous expression of Oct4 alone is sufficient for reprogramming cell types that inherently express the other reprogramming factors ([@bib32], [@bib33], [@bib79], [@bib86]). Most of the substitutes for Oct4 that could successfully reprogram to iPSCs work through the direct activation of endogenous Oct4 gene ([@bib7], [@bib23], [@bib25], [@bib61]). *In vivo*, Oct4 serves as a master regulator, playing an integral role in maintaining pluripotency ([@bib50], [@bib54]) and establishing the inner cell mass during development ([@bib48]).

Intriguing recent studies described Oct4-independent reprogramming cocktails, where Oct4 was replaced with GATA factors ([@bib45], [@bib63], [@bib64]). Shu et al. hypothesized that Oct4 and Sox2 could orchestrate cellular dedifferentiation during reprogramming by counteracting each other's effects in the specification of meso-endoderm and neuroectoderm, respectively. The report demonstrated that endoderm lineage specifiers, such as Gata3, Gata4, and Gata6, promoted even higher-efficiency reprogramming compared to Oct4. This study introduced the "seesaw model" of pluripotency, which describes it as a fine balance between the induction of opposing developmental lineages ([@bib62]).

Our group previously determined that Oct4 is not critical for establishing totipotency during mouse development; moreover, following nuclear transfer, Oct4-null oocytes can still efficiently reprogram somatic nuclei to pluripotency ([@bib87]). The present work was sparked by the surprising observation that a reprogramming cassette that did not contain Oct4 was able to efficiently generate iPSCs, contrary to the long-standing dogma.

Results {#sec2}
=======

SKM Is Sufficient for Reprogramming Mouse Somatic Cells to Pluripotency {#sec2.1}
-----------------------------------------------------------------------

Initially, we removed Oct4 from the widely used tetO-OKSM polycistronic reprogramming cassette ([@bib66]) to generate a negative control to compare the reprogramming ability of different POU factors ([Figure 1](#fig1){ref-type="fig"}A). To our surprise, induction of KSM in Oct4-GFP reporter mouse embryonic fibroblasts (MEFs) (OG2) could still generate GFP^+^ colonies ([Figure 1](#fig1){ref-type="fig"}B). We then deleted Oct4 also from the tetO-OSKM vector ([@bib9], [@bib10], [@bib11]; [Figure 1](#fig1){ref-type="fig"}C). The SKM cassette also gave rise to GFP^+^ and alkaline phosphatase-positive colonies, as early as 5 days post-induction (dpi) ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}B). PCR genotyping confirmed lentiviral integration of SKM/KSM cassettes in all iPSC lines, whereas neither Oct4 transgene nor another POU factor, Brn4, were detected ([Figure 1](#fig1){ref-type="fig"}E).Figure 1Sox2, Klf4, and cMyc Can Reprogram to Pluripotency in the Absence of Exogenous POU Factor(A and C) Scheme of KSM and SKM polycistronic vectors derived from OKSM (A) and OSKM (C) reprogramming cassettes.(B and D) Generation of iPSCs with tetO-KSM (B) and SKM (D) vectors, respectively. Phase-contrast and fluorescence microscopy images of primary colonies and passaged clonal lines of KSM and SKM iPSCs (scale bars represent 250 μm).(E) PCR genotyping verifying tetO-KSM and tetO-SKM transgenes in KSM and SKM iPSC lines, respectively, while confirming the absence of Oct4 or Brn4 integration.(F) Bisulfite sequencing analysis of DNA methylation in *Oct4*, *Nanog*, and *Col1a1* promoters in MEFs and KSM and SKM iPSC lines.(G) H&E staining of teratoma sections with representation of three germ layers (ectoderm: keratinizing epithelium; mesoderm: smooth muscles; endoderm: cuboidal and respiratory epithelium).(H) An adult chimeric mouse generated from SKM iPSC line.(I) Bright-field and GFP merged images of the gonads from E13.5 KSM and SKM iPSC chimeric embryos.(J) Schematic representation of the time course reprogramming experiment.(K) Time course reprogramming experiment of Oct4-GFP MEFs using polycistronic vectors. 10^3^ transduced MEFs were plated on feeders and induced with dox for the indicated number of days. GFP^+^ colonies were counted on 10 dpi. Error bars represent SD; n = 3.(L) Western blot analysis of MEFs after transduction of polycistronic vectors, 1 dpi.

The KSM/SKM (hereafter referred to as SKM) iPSCs displayed morphology characteristic of embryonic stem cells (ESCs) and could be expanded for at least 15 passages ([Figures 1](#fig1){ref-type="fig"}B and 1D). They stained positive for the pluripotency-specific markers SSEA1 and Nanog ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Methylation analysis of bisulfite-treated DNA revealed that the *Oct4* and *Nanog* promoters were hypomethylated ([Figure 1](#fig1){ref-type="fig"}F), indicating epigenetic activation of the pluripotency genes. In contrast, the *Col1a1* promoter was hypermethylated in the reprogrammed cell lines, indicating silencing of the somatic gene. The SKM iPSCs gave rise to all three germ layers in teratoma formation assays ([Figure 1](#fig1){ref-type="fig"}G) and contributed to the development of viable chimeric mice ([Figure 1](#fig1){ref-type="fig"}H), including the germline ([Figure 1](#fig1){ref-type="fig"}I).

SKM Reprogramming Is Independent of Expression Cassette or Starting Cell Type {#sec2.2}
-----------------------------------------------------------------------------

To assess the efficiency and kinetics of SKM versus OSKM reprogramming, we performed a time course reprogramming experiment. OG2 MEFs were transduced with the OSKM, SKM, OSK, OKM, or OSM polycistronic vectors and induced with doxycycline (dox) for 1--8 days ([Figure 1](#fig1){ref-type="fig"}J). SKM generated GFP^+^ colonies after at least 5 days of induction, which is delayed by 2 days compared to OSKM ([Figure 1](#fig1){ref-type="fig"}K). The SKM reprogramming efficiency after 6--8 days of induction was approximately 30% of that for OSKM. Surprisingly, the removal of Oct4 from the OSKM cassette was the least detrimental, while removal of Klf4 led to the biggest drop in reprogramming efficiency. Western blot analysis confirmed comparable factor expression and the absence of the factor eliminated from each cassette ([Figure 1](#fig1){ref-type="fig"}L). The use of MEFs with Gof18;Rosa26-rtTA background gave a very similar result ([Figure S1](#mmc1){ref-type="supplementary-material"}B).

We ruled out the possibility that the tet-inducible promoter or the reverse tetracycline-controlled transactivator (rtTA) is responsible for reprogramming in the absence of Oct4 by demonstrating that EF1α-SKM/KSM could generate GFP^+^ colonies in the absence of rtTA ([Figure S1](#mmc1){ref-type="supplementary-material"}C). We also cloned the KSM cassette into the non-integrating, episomal vector to attempt virus-free reprogramming ([@bib51]). Lipofection of episomal KSM into MEFs generated GFP^+^ colonies that were expanded into stable iPSC lines ([Figure S1](#mmc1){ref-type="supplementary-material"}D) that lost the vector by passage 5 ([Figure S1](#mmc1){ref-type="supplementary-material"}E). We confirmed the pluripotency of integration-free KSM-iPSCs by immunostaining and teratoma assays ([Figures S1](#mmc1){ref-type="supplementary-material"}F and S1G).

To address the question whether SKM reprogramming depends on a specific starting cell population, we transduced presorted Thy^−^ and Thy^+^ subpopulations of MEFs and found that both could be reprogrammed, although SKM induction in Thy^+^ cells gave rise to more GFP^+^ colonies ([Figures S1](#mmc1){ref-type="supplementary-material"}H--S1J). We also demonstrated that adult lung fibroblasts ([Figure S1](#mmc1){ref-type="supplementary-material"}K), immortalized adult tail tip fibroblasts ([Figure S1](#mmc1){ref-type="supplementary-material"}L), and cortical astrocytes ([Figures S1](#mmc1){ref-type="supplementary-material"}M--S1P) could be reprogrammed in the absence of exogenous Oct4. Overall, the efficiency of SKM reprogramming appeared to correlate with the rate of cell division, but not the origin of the cells.

Reprogramming in the Absence of Oct4 Relies on High Cell Proliferation Rate {#sec2.3}
---------------------------------------------------------------------------

To further understand the components driving SKM reprogramming, we dissected the reprogramming cassettes. We found that neither KS nor SK can reprogram alone, but each could generate GFP^+^ colonies when combined with Oct4 or cMyc ([Figure 2](#fig2){ref-type="fig"}A). We used three different concentrations of dox to induce different levels of reprogramming factor expression. Although even the lowest expression level (10 ng/mL of dox) was sufficient for OSKM reprogramming, reprogramming in the absence of Oct4 required higher levels of expression (50 or 1,000 ng/mL dox). Polycistronic expression of the factors appeared to be beneficial, but not crucial, for SKM reprogramming, as SK+M, KS+M, K+SM, and even S+K+M could generate GFP^+^ colonies, albeit with very low efficiency in the case of monocistronic induction. Klf4-IRES-Sox2 (KS)+M could generate iPSCs with efficiency comparable to KSM, excluding the possibility of a gain-of-function effect from polyproteins that may arise from uncleaved 2A peptides ([@bib81]).Figure 2Highly Proliferative Cells Can Be Reprogrammed by Sox2 and Klf4 Alone(A) Reprogramming Oct4-GFP MEFs with dissected KSM and SKM cassettes. Different levels of transgene expression were achieved by induction with three concentrations of dox: 1 μg/mL (H); 50 ng/mL (M); and 10 ng/mL (L; see the tetO-mCherry panel, right). GFP^+^ colonies were counted after 7 and 14 dpi. Error bars represent SD; n = 3; scale bars represent 250 μm.(B) Bright-field and Oct4-GFP merged overview images of Sox1-KM and Sox2-KM iPSCs after 14 dpi (scale bars represent 1 mm).(C) Reprogramming of Oct4-GFP MEFs with Sox2-KM or Sox1-KM polycistronic cassettes in combination with Oct4, Gata4, or Gata6. Different level of transgene expression was achieved by induction with 1 μg/mL or 50 ng/mL of dox for 12 days. GFP^+^ colonies were counted on D14. Error bars represent SD; n = 3.(D) Reprogramming of SV40LT-immortalized Oct4-GFP MEFs by ectopic expression of Sox2-Klf4 bicistronic cassette in combination with Oct4, cMyc, Gata4, or Gata6. Error bars represent SD; n = 3. Statistical significance was calculated with Student's t test.(E) Cell proliferation assay. 2,000 MEFs were transduced with indicated constructs in 96-well plates. The cells were harvested and counted after 0, 2, 4, and 6 dpi. SK sample was used as control for calculation of statistical significance. Error bars represent SD; n = 3. Statistical significance was calculated with Student's t test.

It was reported that the endoderm-specific GATA factors could substitute for Oct4 in reprogramming to pluripotency, while ectoderm-specific Sox1 or Sox3 could replace Sox2 ([@bib63], [@bib64]). We replaced Sox2 with Sox1 and observed only a 50% decrease in reprogramming efficiency for both the SKM and OSKM cocktails ([Figures 2](#fig2){ref-type="fig"}B and 2C). Adding Gata4 or Gata6 did not significantly increase the reprogramming efficiency for either Sox2-KM or Sox1-KM at a high level of transgene expression but increased the number of GFP^+^ colonies at lower level of induction ([Figure 2](#fig2){ref-type="fig"}C).

We next tested whether Gata4 or Gata6 could reprogram in combination with SK only. Indeed, as reported by [@bib63], SK+Gata4/6 could generate iPSCs; however, the efficiency of reprogramming was 10 times lower than for SK+O or SK+M ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). Moreover, SK+GATA did not generate any GFP^+^ colonies when induced with a lower dox concentration ([Figure S2](#mmc1){ref-type="supplementary-material"}A).

Given that GATA factors, Oct4, and cMyc share the ability to activate proliferation genes, we next questioned whether SK alone could reprogram highly proliferative cells. We introduced a tet-inducible SV40 Large T antigen (SV40LT) lentiviral vector into MEFs, allowing us to reversibly immortalize fibroblasts during the reprogramming process ([@bib3]). The immortalization of the starting MEFs allowed for reprogramming with SK only and rendered the addition of cMyc, Gata4, or Gata6 ineffective ([Figures 2](#fig2){ref-type="fig"}D, [S2](#mmc1){ref-type="supplementary-material"}C, and S2D). SK iPSCs ([Figure S2](#mmc1){ref-type="supplementary-material"}E) could be passaged at least 12 times while preserving the normal karyotype ([Figure S2](#mmc1){ref-type="supplementary-material"}F). We verified their genomic integrations by PCR genotyping and their pluripotency by immunostaining, teratoma formation, and chimera contribution, including the germline ([Figures S2](#mmc1){ref-type="supplementary-material"}G--S2K).

Cell proliferation assay through the course of reprogramming showed that the addition of Gata4 or Gata6 significantly increased the proliferation of fibroblasts, resulting in 2-fold increase in cell number after 6 dpi compared to SK alone ([Figure 2](#fig2){ref-type="fig"}E). Thus, we conclude that GATA factors when combined with SK could reprogram fibroblasts by increasing the proliferation rate in a manner similar to cMyc and SV40LT.

SKM iPSCs Exhibit Dramatically Enhanced Developmental Potential {#sec2.4}
---------------------------------------------------------------

We next evaluated the developmental potential of SKM iPSCs by performing the most stringent test for pluripotency, tetraploid (4N) complementation assay ([Figure 3](#fig3){ref-type="fig"}A; [@bib46]). In this method, the tested iPSCs are aggregated with 4N embryos that can form extra-embryonic tissues but fail to develop viable inner cell mass. Development of such aggregates results in a fetus consisting almost exclusively of iPSCs (all-iPSC mice). We tested 13 clonal tet-inducible iPSC lines derived from Gof18-Rosa26-rtTA MEFs (5 SKM, 3 KSM, and 5 OSKM lines) of the same passage that were generated and cultured in parallel. All the tested lines were preselected for minimal transgene leakage to avoid possible harmful developmental effects ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Additionally, we generated control ESC lines from F1 embryos derived by mating SKM\#1 all-iPSC mice to achieve the closest matching genotype. All SKM iPSC lines were capable of generating full-term all-iPSC pups (4N-on; [Figures 3](#fig3){ref-type="fig"}B and 3C; [Table S2](#mmc1){ref-type="supplementary-material"}). In contrast, only 3 of 5 OSKM lines were 4N-on ([Figure 3](#fig3){ref-type="fig"}C), corroborating published reports ([@bib2], [@bib8], [@bib15]). Astonishingly, 44.1% ± 9.1% of SKM iPSC- and 27.1% ± 17.5% of ESC-aggregated embryos gave rise to fully developed pups, compared to only 2.3% ± 1.4% for OSKM iPSCs ([Figure 3](#fig3){ref-type="fig"}D). The 4N complementation efficiency for OSKM lines was comparable to those of other reports ([Figure S3](#mmc1){ref-type="supplementary-material"}B), whereas the efficiency of SKM iPSCs was much higher than that of OSKM iPSCs or iPSCs generated by alternative cocktails---Oct4+Tet1 (OT) or Sall4+Nanog+Esrrb+Lin28 (SNEL)---which were reported to improve iPSC quality ([@bib8], [@bib15]; [Figures 3](#fig3){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}B). Notably, none of the OSKM all-iPSC pups survived foster nursing ([Figure S3](#mmc1){ref-type="supplementary-material"}B), while 49.5% of SKM all-iPSC pups survived for at least 2 days of foster nursing and 34% survived until adulthood ([Figure 3](#fig3){ref-type="fig"}D). All adult SKM all-iPSC mice were healthy and fertile ([Figures 3](#fig3){ref-type="fig"}E and 3F). Additionally, we tested 6 integration-free iPSC lines generated by episomal vectors ([Figures S1](#mmc1){ref-type="supplementary-material"}D--S1F). The results were largely consistent: all tested episomal KSM (epiKSM) iPSC lines were 4N-on, while only 1 of 3 epiKSM+O lines was 4N-on, albeit of high quality ([Figure 3](#fig3){ref-type="fig"}C; [Table S2](#mmc1){ref-type="supplementary-material"}). The higher variability of episomal comparing to tet-inducible lines is expected, due to the stochastic nature of episomal disappearance and, therefore, lack of factor expression control ([@bib52]). Nevertheless, the rare appearance of a high-quality epiKSM+O line suggests that certain conditions, such as lower expression, fast vector disappearance, or a certain O:KSM ratio, could allow for high-quality iPSCs, even in the presence of Oct4.Figure 3Omitting Oct4 in the Reprogramming Cocktail Increases the Quality of iPSCs(A) Schematic representation of tetraploid complementation experiment.(B) All-iPSC pups generated by tetraploid complementation assay with SKM\#1 iPSC line. 23 aggregates were transferred to 2 pseudopregnant CD-1 (white) females.(C) The total ratios of 4N-on versus 4N-off iPSC and ESC lines generated in this study compared to published data.(D) Percentage of 4N-aggregated embryos derived from tetO-OSKM, SKM/KSM iPSCs or ESCs that gave rise to full-term pups, pups that initiated breathing, pups that survived foster-nursing for at least 48 h, and those survived to adulthood (at least 3 months). Bars are representing the mean between all tested lines. The statistical significance was determined by Mann-Whitney test. Error bars represent SEM.(E) 6-month-old all-iPSC mice generated by tetraploid complementation assay with SKM\#1 iPSC line.(F) PCR genotyping of F1 offspring of SKM and KSM all-iPSC mice for SKM or KSM transgenes, respectively.

Taken together, the SKM cocktail generates iPSCs with exceptionally high developmental potential, nearly 20-fold higher than that of OSKM, suggesting that exogenous Oct4 detrimentally affects the quality of iPSCs.

Co-expression of Sox2 and cMyc Causes Immediate Retroviral Silencing in Fibroblasts {#sec2.5}
-----------------------------------------------------------------------------------

We hypothesized that early silencing of Moloney murine leukemia virus (MMLV)-based vectors could account for the contradictory data presented in numerous publications reporting the indispensability of Oct4 in the Yamanaka cocktail ([Table S1](#mmc1){ref-type="supplementary-material"}). It is commonly accepted that silencing of retroviral transgenes is a distinct characteristic of pluripotent, but not somatic, cells ([@bib26]).

We transduced OG2 MEFs with a retroviral pMX vector expressing mCherry to track the retroviral silencing during reprogramming. Surprisingly, the morphological changes of SKM- and OSKM-induced fibroblasts coincided with the loss of mCherry signal starting as early as 2 dpi ([Figures 4](#fig4){ref-type="fig"}A, [S4](#mmc1){ref-type="supplementary-material"}A, and S4B). Later, mCherry^−^ cells formed dome-shaped colonies, within which Oct4-GFP^+^ cells emerged ([Figures 4](#fig4){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}B). We quantified the results of time course fluorescence-activated cell sorting (FACS) analysis during OSKM and SKM reprogramming ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Although half of the fibroblasts had already lost mCherry expression after 2 dpi, a third of the mCherry^+^ cells still expressed fibroblast-specific Thy1, but the majority became double-negative by 4 dpi. These data suggest that retroviral silencing occurs very early during lentivirus-driven reprogramming---even before the loss of somatic cell identity.Figure 4Co-expression of Sox2 and cMyc Leads to Immediate Retroviral Silencing in MEFs(A) Time course FACS of pMX-mCherry^+^ Oct4-GFP MEFs during OSKM and SKM reprogramming.(B) FACS analysis of pMX-mCherry^+^ MEFs expressing Oct4, Sox2, Klf4, cMyc, and combinations of the factors cloned into tet-inducible polycistronic vector with IRES-Puro on D3 of induction and puromycin selection.(C) Experimental design to follow the fate of cells that did or did not undergo retrovirus silencing by 3 dpi with OSKM or SKM.(D) Reprogramming of pMX-mCherry^+^ Oct4-GFP MEFs with OSKM or SKM. The cells were sorted for mCherry after 3 dpi and plated on a feeder layer. GFP^+^ colonies were counted after 7 and 14 dpi. Error bars represent SD; n = 3. Statistical significance was calculated with Student's t test.(E) Experimental design of time course SKM versus OSKM reprogramming RNA-seq experiment.(F) Heatmap showing the Spearman correlation coefficient between time course reprogramming samples based on RNA-seq data.(G) Heatmap depicting the relative fold change (FC) of gene expression after induction with OSKM or SKM. The selected genes were reported as top 100 hits in systemic siRNA screen for reactivation of retrovirus in pluripotent stem cells ([@bib89]). Hierarchical clustering was based on Euclidean distance.

If such immediate silencing occurred during retrovirus-mediated reprogramming, it would preclude conversion of fibroblasts into iPSCs. Indeed, when pMX-mCherry^+^ cells were infected with retroviral Oct4, Sox2, Klf4, and cMyc, some groups of cells lost mCherry expression and reprogramming was halted ([Figure S4](#mmc1){ref-type="supplementary-material"}D). GFP^+^ cells could only arise from within mCherry^+^ clusters that kept expressing the transgenes. Thus, reprogramming with MMLV-based vectors selects for the cells that do not undergo early retroviral silencing.

We dissected the tetO-OSKM cassette to identify the exact factors driving early retrovirus silencing. We cloned the reprogramming factors into a tet-inducible vector carrying IRES-Puro, allowing for the selection of infected cells. Although none of the factors could trigger silencing when induced alone, simultaneous expression of Sox2 and cMyc (SM) was sufficient to silence the retroviral transgene in most of the cells by 3 dpi ([Figure 4](#fig4){ref-type="fig"}B).

We tracked the reprogramming fate of the cells that did or did not undergo early retroviral silencing. We sorted the cells on d3 after SKM or OSKM induction and selection and plated the cells on a feeder layer to assess their reprogramming fate ([Figure 4](#fig4){ref-type="fig"}C). Overall, the mCherry^−^ populations gave rise to a significantly higher number of GFP^+^ colonies than the mCherry^+^ populations for both reprogramming conditions. Although in the case of OSKM reprogramming, the same number of mCherry^−^ cells gave 4 times more GFP^+^ colonies than the mCherry^+^ cells, in the case of SKM, the mCherry^−^ fraction gave nearly 50 times more colonies than the mCherry^+^ fraction ([Figure 4](#fig4){ref-type="fig"}D). We therefore confirmed that retroviral silencing occurs early during the reprogramming, which is particularly relevant for SKM induction. Altogether, these results suggest the infeasibility of retrovirus-driven SKM reprogramming ([Figure S1](#mmc1){ref-type="supplementary-material"}C).

Retrovirus Silencing Machinery Is Established Already after 48 h of Reprogramming {#sec2.6}
---------------------------------------------------------------------------------

To gain deeper insight into the mechanism of SKM reprogramming, we performed RNA sequencing (RNA-seq) over the course of reprogramming ([Figure 4](#fig4){ref-type="fig"}E). The pMX-mCherry^+^ OG2 MEFs were transduced with polycistronic SKM or OSKM; samples were collected after 2, 4, 6, 9, and 12 dpi. Only mCherry^−^ cells were used for RNA isolation to reduce heterogeneity and to eliminate contamination by untransduced cells. Additionally, we sequenced subpopulations of reprogramming intermediates that underwent mesenchymal to epithelial transition (MET) on d6 (mCherry^−^/GFP^−^/Epcam^+^) or activated endogenous Oct4 (mCherry^−^/GFP^+^) on d9 and d12 (2 days after dox withdrawal; [Figure S4](#mmc1){ref-type="supplementary-material"}E). Global hierarchical clustering with Spearman correlation as a distance metric revealed that iPSCs as well as d12 samples clustered close to ESCs and far from starting MEFs, while d2--d9 samples clustered in between ([Figure 4](#fig4){ref-type="fig"}F).

Previously, [@bib89] carried out a genome-wide small interfering RNA (siRNA) screen that uncovered the components mediating retrovirus silencing in pluripotent stem cells. We analyzed the expression of the top 100 genes implicated in retroviral silencing in our samples. Remarkably, by d2 of SKM or OSKM induction, the expression of this gene subset already resembled that of ESCs ([Figure 4](#fig4){ref-type="fig"}G). Among the genes upregulated on d2 were key drivers of retrovirus silencing: chromatin remodeling by histone chaperones (*Chaf1a/b* and *Smarcc1*), sumoylation factors (*Sumo2*, *Ube2i*, *Sae1*, *Uba2*, and *Ube2j2*), and chromatin modifiers (*Trim28*, *Setdb1*, and *Mphosph8*). Therefore, we conclude that the retrovirus repressor machinery of pluripotent cells can be established in fibroblasts already around 2 days of SKM or OSKM induction.

Oct4 Is Not Required for Initiation of Pluripotency Program in Somatic Cells {#sec2.7}
----------------------------------------------------------------------------

To compare the molecular roadmaps of SKM and OSKM reprogramming, we analyzed gene expression relevant for established reprogramming stages: fibroblast identity loss; MET; and maturation of pluripotency ([@bib36], [@bib55], [@bib69]). RNA-seq data showed that downregulation of fibroblast-specific genes (*Snai1*, *Thy1*, *Ncam1*, etc.) starts as early as d2 of OSKM or SKM expression and advances synchronously for both conditions ([Figures 5](#fig5){ref-type="fig"}A and 5C). Loss of fibroblast identity, therefore, appears to be independent of exogenous Oct4 expression. MET occurs on d2--d4 for OSKM and d2--d6 for SKM reprogramming, as evident from upregulation of epithelial markers (e.g., *Cdh1*, *Epcam*, and *Esrp1*; [Figure 5](#fig5){ref-type="fig"}B). The partially delayed MET in the absence of Oct4 is in accordance with our FACS data showing fewer Epcam^+^ cells on 6 dpi for SKM versus OSKM ([Figure S4](#mmc1){ref-type="supplementary-material"}E).Figure 5SKM Can Activate Pluripotency Program in *Oct4*-KO MEFs(A and B) Time course expression plots of indicated fibroblast (A) and MET (B) genes during OSKM and SKM reprogramming. Only Epcam^+^ and GFP^+^ sorted samples are shown for d6 and d9, respectively.(C) Time course expression of MEF- and ESC-specific genes ([@bib17]). Only differentially expressed genes (DEGs) with FC ≥ 4 were plotted.(D) Time course expression plots of indicated genes during OSKM and SKM reprogramming.(E) Time course expression of Oct4, Nanog (ChIP-Atlas), and Sall4 ([@bib37]) targets in ESCs. Only top peaks (macs score ≥ 200, on Chip-Atlas) within 5 kb of DEGs (FC ≥ 4 in iPSCs versus MEFs) were plotted.(F) qPCR gene expression analysis of *Nr5a2*, *Nanog*, and *Sall4* after short hairpin RNA (shRNA)-driven KD during reprogramming after 2 dpi with OSKM. *ActB* was used as a reference gene. Error bars represent SD; n = 3.(G) Reprogramming of Oct4-GFP MEFs, expressing *Nr5a2*, *Nanog*, *Sall4*, or control shRNAs with OSKM or SKM. GFP^+^ colonies were counted after 7 and 14 dpi. Error bars represent SD; n = 3. Statistical significance was calculated with Student's t test.(H) Strategy for generating *Pou5f1* (Oct4)-KO MEFs.(I) PCR genotyping confirming homozygous deletion of Oct4 in 3 MEF lines.(J) Immunofluorescence imaging of Oct4^F/F^ and Oct4^Δ/Δ^ MEFs reprogrammed with SKM, on 7 dpi.(K) qPCR gene expression analysis of Epcam^+^ Oct4^F/F^ and Oct4^Δ/Δ^ MEFs reprogrammed with OSKM or SKM on 7 dpi. Error bars represent SD; n = 3.

The maturation stage of reprogramming, marked by upregulation of pluripotency-specific genes, is largely delayed for SKM reprogramming ([Figure 5](#fig5){ref-type="fig"}C). Expression plots confirm the absence of Oct4 in SKM and similar levels of Sox2 in SKM versus OSKM samples ([Figure 5](#fig5){ref-type="fig"}D). Although some genes (e.g., *Lin28a*, *Nr5a2*, and *Ccnb1*) are upregulated with comparable kinetics for both conditions, other genes are delayed in the absence of Oct4 (e.g., *Nanog*, *Tfcp2l1*, and *Esrrb*). Activation of Oct4 direct targets ([Figure 5](#fig5){ref-type="fig"}E), such as *Fut9* (SSEA1) and *Utf1* ([Figure 5](#fig5){ref-type="fig"}D), are among the most delayed in SKM versus OSKM reprogramming, while Nanog and Sall4 targets show less delayed kinetics ([Figure 5](#fig5){ref-type="fig"}E).

To understand how endogenous *Oct4* is activated during SKM reprogramming, we performed gene knockdown (KD) experiments with 3 candidate factors, Nr5a2, Nanog, and Sall4 ([Figure 5](#fig5){ref-type="fig"}F), which showed relatively early upregulation according to the RNA-seq data. All 3 factors were previously reported as Oct4 substitutes in reprogramming ([@bib7], [@bib25]). Nr5a2 KD did not affect the efficiency of SKM reprogramming ([Figure 5](#fig5){ref-type="fig"}G). Nanog or Sall4 KD, on the other hand, dramatically reduced the number of SKM iPSC colonies but had substantially weaker effects on OSKM reprogramming. Time course immunostaining confirmed that SKM activates Nanog ([Figure S5](#mmc1){ref-type="supplementary-material"}A) prior to Oct4 during reprogramming.

The gene profiling combined with KD experiments suggests that Nanog and Sall4 are the first pluripotency regulators to be activated during SKM reprogramming, although endogenous *Oct4* is upregulated in a secondary activation wave. To further understand the role of endogenous *Oct4* in SKM reprogramming, we generated Oct4-knockout (KO) fibroblasts ([Figure 5](#fig5){ref-type="fig"}H). The MEFs derived from *Oct4*^*flox/flox*^*; Rosa26-CreERT2* mice were treated with tamoxifen and immortalized with tetO-SV40LT. Clonal MEFs were picked to ensure homozygous deletion of the *Oct4* alleles ([Figure 5](#fig5){ref-type="fig"}I). Immunostaining showed that induction of SKM could activate Nanog and Sall4 in the complete absence of Oct4 ([Figure 5](#fig5){ref-type="fig"}J). qPCR analysis of Epcam^+^ cells after 7 dpi showed that SKM can downregulate fibroblast-specific genes (*Thy1* and *Slug*) and activate MET (*Epcam* and *Cdh1*) and the pluripotency genes (*Nanog*, *Sall4*, *Lin28*, and *Tfcp2l1*) in Oct4-KO MEFs ([Figure 5](#fig5){ref-type="fig"}K). However, some late pluripotency genes (e.g., *Esrrb* and *Rex1*) were only partially upregulated, and Oct4-KO SKM pre-iPSCs could not survive dox withdrawal, suggesting that Oct4 is still needed for finalizing establishment of and for maintaining pluripotency.

Oct4 Overexpression Diverts Cells from a Direct Route to Pluripotency {#sec2.8}
---------------------------------------------------------------------

To compare the global gene expression changes occurring during OSKM and SKM reprogramming, we performed two dimensionality reduction methods: principle-component analysis (PCA) and t-distributed stochastic neighbor embedding (t-SNE) analysis ([Figures 6](#fig6){ref-type="fig"}A, 6B, and [S6](#mmc1){ref-type="supplementary-material"}A). As reported previously ([@bib55]), PCA shows that OSKM-reprogrammed cells transiently divert from a direct route to pluripotency on d6, d9, and d12 in the PC2 dimension or even partially re-acquire MEF identity in PC3 dimension ([Figures 6](#fig6){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}A). In contrast, SKM reprogramming occurs along a more direct PC2 trajectory and diverts further from MEFs in PC3. t-SNE analysis shows an even clearer distinction between SKM and OSKM samples, starting already on 4 dpi.Figure 6Exogenous Oct4 Diverts the Cells from Direct Route to Pluripotency(A and B) PCA (A) and t-SNE (B) analysis of global gene expression in time course samples during OSKM and SKM reprogramming.(C) Heatmap depicting the relative FC of gene expression during the course of SKM and OSKM reprogramming based on RNA-seq. Hierarchical clustering was based on Euclidean distance.(D) Time course plots of representative GO terms of gene cluster characterized by specific kinetics (see [Figure S5](#mmc1){ref-type="supplementary-material"}A). Gene set enrichment analysis was performed by DAVID (enrichment \> 2; p \< 0.01; false discovery rate \[FDR\] \< 0.1).(E and F) Time course average expression of Oct4 off targets in MEFs ([@bib16]), Suz12 targets in ESCs ([@bib53]; E), and p300 targets in ESCs or preiPSCs ([@bib17]; F). Line graph depicts the average *Z* score values of expression; shading depicts SD.

It was reported that SKM induction in fibroblasts leads to elevated expression of ectodermal genes, which can be counterbalanced by Oct4 or GATA factors, resulting in pluripotency induction ([@bib63]). However, other studies suggested that OSKM reprogramming also leads to transient elevation of ectodermal genes ([@bib24], [@bib44]). We compared the effects of SKM with OSKM reprogramming on the expression of ecto-, meso-, and endodermal genes. The mesodermal genes are quickly downregulated after OSKM or SKM induction (e.g., *Snai1*, *Snai2*, and *Chrd*), which coincides with loss of fibroblast identity ([Figure 6](#fig6){ref-type="fig"}C). Endodermal genes remain largely unaffected throughout reprogramming; however, in contrast to the report by [@bib63], many ectodermal genes are transiently upregulated during both SKM and OSKM reprogramming. Moreover, OSKM causes much stronger ectodermal induction (e.g., *Krt1*, *Evpl*, and *Nes*), with some ectodermal genes upregulated only in the presence of exogenous Oct4 (e.g., *Lor*, *Elf5*, *Krt84*, and *Sprr3*; [Figure 6](#fig6){ref-type="fig"}C). Importantly, sorted d6 Epcam^+^ and d9 Oct4-GFP^+^ samples show even sharper difference in ectodermal upregulation in OSKM versus SKM reprogramming.

We performed soft clustering to subdivide differentially expressed genes (DEGs) into groups that have similar expression kinetics during reprogramming ([Figure S6](#mmc1){ref-type="supplementary-material"}A). SKM cluster 4, enriched in somatic genes, exhibits rapid downregulation for both conditions. A few genes in this subset, however, are transiently reactivated during the later stages of OSKM reprogramming ([Figure 6](#fig6){ref-type="fig"}D). The opposite happens for OSKM cluster 2, enriched in metabolic genes, which shows a sharp upregulation followed by a transient decline on 4--9 dpi for OSKM, but not SKM. These clusters are likely responsible for the partial return of a fibroblast identity in OSKM samples in PC3 dimension ([Figure S6](#mmc1){ref-type="supplementary-material"}A). OSKM cluster 4 contains 1,260 genes, enriched in terms related to epidermis development, which were strongly transiently upregulated on 4--9 dpi with OSKM but remained largely unaffected during SKM reprogramming ([Figures 6](#fig6){ref-type="fig"}D and [S6](#mmc1){ref-type="supplementary-material"}C). These changes coincide with the departure of OSKM samples from a direct trajectory to pluripotency in the PC2 plane ([Figure 6](#fig6){ref-type="fig"}A). Gene set enrichment analysis of d9 GFP^+^ OSKM versus SKM samples showed GO terms related to epidermis development among the top enriched ([Figures S6](#mmc1){ref-type="supplementary-material"}D and S6E). On the other hand, the GO terms related to RNA processing, translation, DNA replication, and telomerase maintenance were enriched in d9 GFP^+^ SKM samples ([Figure S6](#mmc1){ref-type="supplementary-material"}D). Many of OSKM cluster 4 genes are direct Oct4 targets when induced in MEFs but are not bound by Oct4 in ESCs; among those are the above-mentioned keratinocyte-related genes *Elf5*, *Krt84*, and *Sprr3* ([Figures 6](#fig6){ref-type="fig"}C and 6E).

Interestingly, OSKM drives a transient upregulation of genes bound by Suz12 in ESCs ([Figure 6](#fig6){ref-type="fig"}E). Suz12, a component of the polycomb repression complex 2 (PRC2), is recruited to poised enhancers in ESCs, preventing them from being transcribed even when bound by TFs ([@bib13]). Among the genes co-bound by Oct4 and Suz12 in ESCs is *Nt5e* (CD73), an immune-response-related cell-surface antigen used by multiple studies as a marker for partially reprogrammed cells ([@bib30], [@bib94]). We found that *Nt5e* is strongly upregulated during OSKM, but not SKM, reprogramming. Active ESC enhancers marked by p300, on the other hand, show gradual upregulation during the course of both OSKM and SKM reprogramming, with faster activation in the presence of Oct4, coinciding with faster reprogramming kinetics ([Figure 6](#fig6){ref-type="fig"}F). However, OSKM induction transiently recruits p300 and upregulates off-target "pre-iPSC" genes to a higher degree than SKM ([Figure 6](#fig6){ref-type="fig"}F).

Overall, our time course gene expression data reveal that the reprogramming trajectories of OSKM and SKM differ predominantly because of profound off-target gene activation driven by ectopically expressed Oct4.

Omitting Exogenous Oct4 Leads to More Faithful Epigenetic Reprogramming {#sec2.9}
-----------------------------------------------------------------------

Previous reports have compared iPSCs versus ESCs in 4N complementation assays and found that iPSCs had impaired developmental potential due to loss of imprinting (LOI), karyotypic instability, aberrant gene expression, and mitochondrial defect ([@bib8], [@bib70], [@bib71], [@bib88], [@bib93]). We tested OSKM and SKM iPSCs for those abnormalities. G-band karyotyping showed that the majority of PSC lines had a normal karyotype ([Figure S7](#mmc1){ref-type="supplementary-material"}A; [Table S2](#mmc1){ref-type="supplementary-material"}), with the exception of OSKM iPSC\#5, KSM iPSC\#3, and ESC\#3 lines, which had trisomy of chromosomes 14, 1, and 19, respectively ([Table S2](#mmc1){ref-type="supplementary-material"}). Additionally, karyotyping of OSKM- and SKM-sorted GFP^+^ bulk iPSCs on the second passage showed no significant difference in the rate of chromosomal aberration between the two reprogramming cocktails ([Figure S7](#mmc1){ref-type="supplementary-material"}B). Electron microscopy of 4N-off and 4N-on lines shows no difference in their subcellular organization; the mitochondria of 4N-off OSKM iPSCs exhibit normal cristae structure indistinguishable from SKM iPSCs or ESCs ([Figure S7](#mmc1){ref-type="supplementary-material"}C).

We compared the gene expression in all tested OSKM and SKM iPSCs, including those generated by the episomal method, as well as ESC lines---altogether 23 lines. Although some high-quality tet-inducible SKM lines clustered the closest to 4N-on ESCs, other lines clustered more randomly. Particularly, all the episomal iPSCs cluster further away from ESCs comparing to lentiviral iPSCs ([Figure 7](#fig7){ref-type="fig"}A). DE analysis of 15 4N-on versus 4 4N-off iPSCs or 8 highest versus 6 lowest quality iPSC lines by DESeq2 showed no significantly up- or downregulated genes ([Figure 7](#fig7){ref-type="fig"}B). We therefore hypothesized that the key might lie in the epigenetic marks, which affect the differentiation of iPSCs.Figure 7OSKM, but Not SKM, Reprogramming Leads to Loss of Imprinting (LOI) and Alterations of iPSC Differentiation during Embryo Development(A) Hierarchical clustering analysis of the iPSC and ESC lines based on global gene expression. Clustering was based on Euclidean distance.(B) MA plots displaying differentially expressed (DE) genes in 4 4N-off OSKM lines versus 15 4N-on iPSC lines and 6 low- versus 8 high-quality iPSCs (4N complementation efficiency of ≤2% and ≥30%, respectively). No DEG with p adj \< 0.05 were found. The analysis was performed using DESeq2 package. Genes with at least 5 reads in any sample were considered.(C) Bisulfite sequencing analysis of DNA methylation in *Gtl2* and *Zrsr1* in representative iPSC lines validating the COBRA results from [Figure S7](#mmc1){ref-type="supplementary-material"}D.(D) E9.5 embryos generated by 4N complementation with mCherry-labeled SKM and OSKM iPSCs (scale = 500 μm).(E) PCA analysis of bulk RNA-seq data of mCherry^+^ cells from E9.5 embryos generated by 4N-complementation with high- or low-quality iPSCs.(F and G) Venn diagrams showing the overlap between down- and upregulated DEGs in 3 differentiated 4N-off OSKM iPSCs at E9.5 (≥5 reads in any sample; FC \> 1.2; p \< 0.05 by DESeq2) and the top gene ontology (GO) term enriched in DEGs overlapping in at least 2 of 3 lines.(H) Venn diagrams showing the overlap between upregulated DEGs from (F) and transiently upregulated DEGs for d6 Epcam^+^ or d9 Oct4-GFP^+^ OSKM versus SKM samples (≥5 reads in any sample; FC \> 2; p \< 0.05 by DESeq2).(I) Gene set enrichment analysis of overlapping genes from (H). The analysis was performed using Enrichr web server. The bars represent combined Enrichr scores.(J) Adapted Waddington's epigenetic landscape model showing an epigenetic landscape with trajectories representing reprogramming from fibroblasts to pluripotency driven by OSKM or SKM cocktails.

Indeed, the analysis of imprinted loci methylation revealed that 3 of 4 4N-off lines showed LOI in *Zrsr1*, *Peg10*, or *Gtl2* loci, as determined by combined bisulfite restriction analysis (COBRA) ([Figure S7](#mmc1){ref-type="supplementary-material"}D) and validated by bisulfite sequencing ([Figure 7](#fig7){ref-type="fig"}C). On the other hand, all SKM and 4N-on OSKM iPSCs maintain normal imprinting. LOI of all of these loci was previously shown to occur during reprogramming, and aberrations of *Zrsr1* and *Gtl2* were specifically linked to impaired developmental potential of iPSCs ([@bib11], [@bib12], [@bib75]).

To track the developmental fate of 4N-off OSKM iPSCs, we marked 3 high-quality and 4 low-quality lines (including integration-free ones) with constitutive mCherry expression. We used these iPSCs to generate 4N aggregates and examined the embryos at embryonic day 9.5 (E9.5). All the tested lines could generate viable embryos with no obvious phenotype at this stage ([Figure 7](#fig7){ref-type="fig"}D), and the vast majority of the cells were derived from iPSCs ([Figure S7](#mmc1){ref-type="supplementary-material"}E). We sorted mCherry^+^ iPSC-derived differentiated cells and performed RNA-seq for 3 embryos per iPSC line, as well as 3 control embryos (altogether 24 embryos).

PCA plots showed that all 3 tested high-quality iPSCs (SKM1, epiKSM1, and epiKSMO2) clustered close to control embryos, although the low-quality lines clustered separately, shifting from the control lines on PC1 and PC3 dimensions ([Figure 7](#fig7){ref-type="fig"}E). Moreover, 3 of 4 of these lines (OSKM2, OSKM3, and epiKSMO3) deviate similarly along both dimensions and have many overlapping DEGs ([Figures 7](#fig7){ref-type="fig"}F and 7G), although epiKSMO1 embryos clustered separately ([Figures 7](#fig7){ref-type="fig"}F and [S7](#mmc1){ref-type="supplementary-material"}F). The GO analysis of overlapping downregulated genes showed the strongest enrichment for genes related to heart development ([Figure 7](#fig7){ref-type="fig"}F) but also hindbrain and lung development and histone methylation genes. The upregulated DEGs were enriched for oxidative metabolism ([Figure 7](#fig7){ref-type="fig"}G). We compared the lists of the upregulated genes during embryo development with those transiently upregulated on d6 (Epcam^+^) or d9 (Oct4-GFP^+^) during OSKM, but not SKM, reprogramming and found 311 overlapping genes. Chromatin immunoprecipitation (ChIP) enrichment analysis (ChEA) of these genes showed the most significant enrichment for Suz12 targets (p adj = 5.52 × 10^−12^), suggesting misregulation of PRC2 targets.

Taken together, forceful expression of Oct4 does not significantly interfere with karyotype maintenance, mitochondria structure, or gene expression in iPSCs. However, it leads to epigenetic defects, such as LOI and misregulation of polycomb targets, resulting in a compromised differentiation potential.

Discussion {#sec3}
==========

Since the introduction of iPSC technology in 2006, Oct4 has been considered a uniquely essential factor for reprogramming to pluripotency. In the current study, we found that SKM can reprogram mouse somatic cells with efficiency of 30% of that for OSKM, albeit with delayed kinetics. Reprogramming in the absence of exogenous Oct4 requires high transgene expression, a non-retroviral reprogramming vector, and a high rate of cellular proliferation.

Silencing of retroviral transgenes is a prominent feature of pluripotent stem cells, but not of other cell types ([@bib49], [@bib72], [@bib89]). Retroviral suppression is thought to occur in the final stage of reprogramming and to be a reliable feature distinguishing fully from partially reprogrammed iPSCs ([@bib5], [@bib26]). Here, we report that the simultaneous expression of Sox2 and cMyc leads to immediate retroviral silencing ([Figures 4](#fig4){ref-type="fig"} and [S4](#mmc1){ref-type="supplementary-material"}). The gene profiling analysis revealed that fibroblasts activate the key components of retrovirus silencing machinery as early as 2 dpi, demonstrating an inadequacy of using retroviral silencing as a marker for mature iPSCs.

During embryonic development, Oct4 is required for specification of the primitive endoderm and mesoderm ([@bib21], [@bib91]) and Sox2 for the neuroectoderm lineage ([@bib19]). Nonetheless, an abundance of published data demonstrate that the two factors act cooperatively to regulate their target genes to induce or maintain pluripotency ([@bib14], [@bib17], [@bib41], [@bib58], [@bib68]). Additionally, Oct4 overexpression can rescue pluripotency in Sox2-KO ESCs ([@bib43]) and the enhanced transcriptional activity of Oct4 can compensate for the omission of Sox2 during reprogramming ([@bib42], [@bib83]), suggesting an overlap rather than opposition between the two factors. Our work suggests that Sox2 and Klf4 do not need a counterbalance by meso-endodermal factors, as was proposed by the seesaw model ([@bib63]), but rather they require an additional factor to boost cell proliferation.

GATA factors are known to regulate proliferation of different cell types. For example, Gata3 controls the proliferation of T cells by upregulating cMyc ([@bib84]), Gata4 regulates proliferation of cardiomyocytes by directly activating cyclin D2 and Cdk4 ([@bib59]), and Gata6 promotes growth of hair follicle progenitor cells by directly activating N-Myc ([@bib85]). We showed that only Oct4, but not cMyc or GATA factors, could enhance the SK reprogramming of highly proliferative SV40LT-immortalized cells and confirmed that GATA factors increase the proliferation rate of SK-induced cells ([Figures 2](#fig2){ref-type="fig"}D and 2E). Our findings, along with those of published reports, challenge the premise that GATA factors have exclusively endoderm-inducing function and suggest that their proliferation-boosting properties could explain their role in reprogramming.

Our data show that the activation of endogenous Oct4 and its targets is delayed during SKM reprogramming, whereas the activation of Nanog and its targets occurs more synchronously in the presence or absence of exogenous Oct4 ([Figures 5](#fig5){ref-type="fig"}D and 5E). We analyzed published ChIP-seq data ([@bib17]) and found that, regardless of the presence of Oct4, Sox2 and Klf4 co-occupied the *Nanog* −5 super-enhancer (SE) already on 2 dpi ([Figure S5](#mmc1){ref-type="supplementary-material"}B). The occupancy at −5 SE locus was lower in Sox2- or Klf4-only samples, suggesting a DNA-binding co-dependency of these two factors. The *Oct4* distal enhancer, on the other hand, was occupied by Sox2 and Klf4 only in the presence of Oct4 at 48 h, suggesting that endogenous *Oct4* cannot be directly activated by SK ([Figure S5](#mmc1){ref-type="supplementary-material"}C).

Nanog, along with Oct4 and Sox2, is a central regulator of the naive pluripotency network ([@bib6], [@bib39], [@bib82]) and plays a crucial role in the final stage of reprogramming to iPSCs ([@bib65]). We showed that depletion of either Nanog or Sall4 did not strongly affect OSKM reprogramming, although it nearly abolished SKM reprogramming ([Figures 5](#fig5){ref-type="fig"}F and 5G). Nanog directly interacts with Sall4 and co-occupies many of the target sites in ESCs, including the *Oct4* locus ([@bib92]). Importantly, SKM induction could downregulate somatic genes and activate MET as well as some pluripotency genes, including *Nanog*, *Sall4*, and *Lin28*, even in Oct4-KO MEFs. Our study indicates that the establishment of pluripotency during SKM reprogramming occurs through direct activation of Nanog, which, in cooperation with Sall4, activates Oct4 and the rest of the pluripotency network ([Figure S5](#mmc1){ref-type="supplementary-material"}D).

Our time course RNA-seq revealed a transient detour from a direct reprogramming trajectory with a prominent upregulation of epidermis-related genes in OSKM intermediates ([Figures 6](#fig6){ref-type="fig"} and [S6](#mmc1){ref-type="supplementary-material"}). An overlap of our RNA-seq data with published ChIP-seq datasets showed that Oct4 directly targets many of the misregulated genes when overexpressed in fibroblasts, but not in ESCs. Moreover, OSKM, but not SKM, reprogramming leads to misregulation of poised genes bound by PRC2 in ESCs and activation of the enhancers specific to "pre-iPSCs," but not ESCs. In summary, OSKM reprogramming suffers from transient off-target gene upregulation driven by Oct4 overexpression, which can be prevented by omitting Oct4 from the reprogramming cocktail.

The relatively poor developmental potential of iPSCs compared to ESCs is a well-known problem that poses a major hurdle for clinical applications of iPSC technology. In agreement with other reports, half of our OSKM iPSCs generated by either lentiviral or episomal methods cannot give rise to all-iPSC mice. Furthermore, the pups generated from 4N-on OSKM lines have drastically reduced survival rates ([Figures 3](#fig3){ref-type="fig"} and [S3](#mmc1){ref-type="supplementary-material"}; [Table S2](#mmc1){ref-type="supplementary-material"}). Thus, pluripotency of the majority of OSKM iPSCs is compromised. In stark contrast, all 11 tested clonal SKM iPSC lines were capable of generating all-iPSC mice, many of which survived to adulthood. LOI is the most widely reported problem associated with a poor developmental outcome of iPSCs ([@bib11], [@bib12]). We found that the majority of 4N-off OSKM lines had LOI in either *Dlk1-Dio3* or *Zrsr1* locus, whereas 4N-on OSKM and all tested SKM iPSCs maintained normal imprinting ([Figures 7](#fig7){ref-type="fig"} and [S7](#mmc1){ref-type="supplementary-material"}). Interestingly, PRC2 can facilitate methylation of imprinted loci and the microRNA (miRNA) expressed from some imprinted loci regulate PRC2, forming a feedback loop ([@bib38]). We found that many transiently upregulated PRC2 targets during OSKM reprogramming were also upregulated during iPSC differentiation within all-iPSC embryos.

A lot of attention has been brought to the reprogramming cocktail components, as even the design of the polycistronic reprogramming cassette can have a dramatic effect on the quality of iPSCs ([@bib11]). The oncogenic potential of cMyc was found to be partially responsible for the poor quality of OSKM iPSCs, as OSK iPSCs showed an increased number of transferred 4N blastocysts that gave rise to full-term pups from 2.6% to 6.5% ([@bib8]). A few groups have reported that alternative reprogramming cocktails could generate iPSCs with improved developmental potential ([Figures 3](#fig3){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}B). For example, SNEL could generate iPSCs at a very low efficiency (0.005%) but with a significantly enhanced developmental potential (from 2.6% to 12.8%; [@bib8]). Here, we report that omitting Oct4 from the reprogramming cocktail allows for the efficient generation of mouse iPSCs (4% total; 30% of OSKM) and increases the average developmental potential of iPSCs from 2.3% to 44.1%---the highest 4N complementation efficiency reported to date.

Oct4, Sox2, and Klf4 are widely considered to be pioneering factors, but their genomic engagement is highly dependent on cofactors and cellular context. Our work suggests that off-target gene activation by Oct4 can potentially have a detrimental effect on the quality of iPSCs. Although we did not address directly whether the mere presence of Oct4 in the beginning of reprogramming or rather its persistent overexpression throughout the process is detrimental, our data suggest that later is the case. Ultimately, this work warrants further development of reprogramming strategies to counterbalance epigenetic aberrations arising from forced expression of reprogramming factors.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rat anti-EpcameBioscience17-5791-82; RRID:[AB_2716944](nif-antibody:AB_2716944){#intref0010}Rat anti-Thy-1.2BioLegend105318; RRID: [AB_492888](nif-antibody:AB_492888){#intref0015}Mouse anti-SSEA1MilliporeMC-480; RRID:[AB_177627](nif-antibody:AB_177627){#intref0020}Mouse anti-Oct4Santa Cruz Biotechnologysc-5279; RRID: [AB_628051](nif-antibody:AB_628051){#intref0025}Goat anti-Sox2Santa Cruz Biotechnologysc-17320; RRID:[AB_2286684](nif-antibody:AB_2286684){#intref0030}Rabbit anti-Klf4Santa Cruz Biotechnologysc-20691; RRID: [AB_669567](nif-antibody:AB_669567){#intref0035}Rabbit anti-cMycSanta Cruz Biotechnologysc-764; RRID: [AB_631276](nif-antibody:AB_631276){#intref0040}Rat anti-NanogeBioscienceeBioMLC-51; RRID:[AB_763613](nif-antibody:AB_763613){#intref0045}Mouse anti-Sall4Santa Cruz Biotechnologysc-101147; RRID: [AB_1129262](nif-antibody:AB_1129262){#intref0050}**Chemicals, Oligos, and Recombinant Proteins**FuGENE6PromegaE269ADoxycycline hyclateSigmaD9891-5GPD0325901Cayman Chemical13034CHIR99021Tocris4423Human LIFPrepared in-houseN/AOligosSigmaSee [Table S3](#mmc1){ref-type="supplementary-material"}**Critical Commercial Assays**GoTag green master mixPromegaM3005SYBR Green PCR MasterApplied BiosystemsABS-4367659EZ DNA Methylation KitZymo ResearchD5001QIAamp DNA mini KitQIAGEN51306NucleoSpin RNAMacherey-Nagel740955.250**Experimental Models: Organisms/Strains**C57BL/6 × C3H miceBred in houseN/ACD1 miceBred in houseN/ARosa25-rtTA, Gof18 miceThis studyN/AOct4flox/flox; Rosa26- Cre ERT2 miceThis studyN/A**Deposited Data**RNA-seqThis studyGEO: [GSE137001](ncbi-geo:GSE137001){#intref0055}**Software and Algorithms**RR Core Team<https://www.R-project.org>DESeq2([@bib40])<http://bioconductor.org/packages/release/bioc/html/DESeq2.html>mFUZZ([@bib35])<http://bioconductor.org/packages/release/bioc/html/Mfuzz.html>CLC 11QIAGEN Bioinformatics<https://qiagenbioinformatics.com>Venny2.1Oliveros, J.C.<https://bioinfogp.cnb.csic.es/tools/venny>Enrichr([@bib34])<http://amp.pharm.mssm.edu/Enrichr/>Geneontology([@bib4])<http://geneontology.org>DAVID([@bib29])<https://david.ncifcrf.gov>

Lead Contact and Materials Availability {#sec4.2}
---------------------------------------

Requests for further information should be directed to and will be fulfilled by Sergiy Velychko (<sergii.velychko@mpi-muenster.mpg.de>). All unique/stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mice {#sec4.3.1}

All mice used were bred and housed at the mouse facility Max Planck Institute (MPI) in Muenster, and animal handling was in accordance with MPI animal protection guidelines. A protocol for animal handling and maintenance for this study was approved by the Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen under the supervision of a certified veterinarian in charge of the MPI animal facility. Mouse embryonic fibroblasts (MEFs) were isolated from male embryos as described previously ([@bib74]).

Method Details {#sec4.4}
--------------

### Cell culture {#sec4.4.1}

MEFs and HEK293T cells were cultured in low-glucose DMEM supplemented with 10% FBS (Ch), 1% Glutamax, 1% penicillin-streptomycin, 1% nonessential amino acids (NEAA), 0.5% β-mercaptoethanol (all from Life Technologies). Mouse embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) were grown on irradiated C3H MEFs in high-glucose DMEM medium (Life Technologies) supplemented with 15% KSR, 2% FCS, 1% Glutamax, 1% NEAA, 1% penicillin-streptomycin, 1% β-mercaptoethanol, and 20 ng/ml human recombinant LIF (purified in-house). The cells were routinely tested for Mycoplasma contamination.

### Vector construction {#sec4.4.2}

pHAGE2-tetO-OKSM (STEMCCA) lentivirus reprogramming vector was kindly provided by Konrad Hochedlinger. All other lentiviral vectors used in this study were cloned into the same pHAGE2 backbone. OSKM was cloned from Col1a 4F2A targeting construct, Addgene \#25794 ([@bib10]) using BamHI and SbfI restriction sites. Mouse Oct4, Sox2, Klf4, cMyc, Gata4, Gata6, and mCherry were amplified by PCR and pasted into pHAGE2-tetO using NotI and ClaI restriction sites. KSM, SKM, KS, SK, and SM were cloned using NotI, ClaI, and available restriction sites (Eco47III in Klf4 and RsrII in Sox2). Bluescript-SV40 Large T antigen (SV40LT) construct was kindly provided by Konstantinos Anastassiadis and cloned into pHAGE2 using available NotI and ClaI restriction sites.

For generation of tetO-ires-Puro vectors, NotI-ClaI-ires-Puro-BstBI was amplified by PCR and inserted by NotI and BstBI (compatible with ClaI, destroyed). The rest of the constructs were inserted into tetO-ires-Puro by restriction with NotI, ClaI, and ligation.

For generation of constitutively expressed pHAGE2-EF1alpha vectors, EF1alpha was PCR amplified and inserted into pHAGE2-tetO constructs with SpeI and NotI, replacing tetO-miniCMV promoter. Retroviral vector pMX-SK was generated by blunt-end ligation of NotI and ClaI‒digested SK fragment.

To generate pCXLE constructs, the NotI-ClaI site was inserted by annealing and ligation oligos to EcoRI-digested pCXLE-GFP (addgene \#27082) ([@bib51]) KSM or Oct4 were inserted using NotI and ClaI digestion and ligation.

shRNA vectors targeting Nr5a2, Nanog, and Sall4 were generated by ligation of annealed oligos into AgeI and EcoRI sites of pLKO-puro (Addgene \#8453) ([@bib73]). The sequences were Nr5a2 5′-GCAAGTGTCTCAATTTAAA-3′ ([@bib25]), Nanog 5′-CTTGCTTACAAGGGTCTGCTA-3′, Sall4 5′- GCAACCTGAAGGTACACTA-3′ ([@bib77]).

### Virus production {#sec4.4.3}

Fully confluent HEK293T cells were split 1 to 5 on 100-mm dishes. The following day, cells were transfected with 3 μg of lentiviral vector, 2 μg of PAX2, and 1 μg of VSV packaging plasmid using Fugene 6 (Roche) according to the manufacturer's instructions. In the case of retrovirus, HEK293T cells were split 1 to 7 and transfected with 2 μg of pMX vector and 2 μg of pCL-Eco. Cells were incubated at 37°C with 5% CO~2~. The virus-containing supernatant was collected and filtered (0.45 μm, Millex-HV, Millipore) 48 h and 72 h after infection. Viral stocks for each experiment were generated simultaneously to ensure equal titers. Virus stocks were titrated by Q-PCR and adjusted accordingly for infections.

### Q-PCR analysis {#sec4.4.4}

Total RNA was extracted using the RNeasy Mini Kit (QIAGEN). cDNA synthesis was performed using the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Transcript levels were determined using iTaq SYBR Green Supermix with ROX (Bio-Rad). Gene expression was normalized to the housekeeping genes Hprt2 and Rlp37A, and calculated using the delta Ct algorithm. Primers are listed in [Table S3](#mmc1){ref-type="supplementary-material"}.

### Reprogramming {#sec4.4.5}

OG2 MEFs or heterozygous ROSA26-rtTA/GOF18 MEFs of passage 3 or 4 were split on 12-well plates (3x10^4^ per well). Simultaneously, the cells were infected with virus-containing supernatant supplemented with 6 μg/ml protamine sulfate (Sigma-Aldrich). 30 μl of non-concentrated tetO-SKM virus and 30 μl of rtTA virus (in the case of OG2 MEFs) were added to 1 mL of fresh medium. The volumes of the rest of the viruses were adjusted accordingly to Q-PCR titration. The cells were washed and medium was replaced with dox-containing (1 μg/ml unless otherwise mentioned) ESC medium (high-glucose DMEM with LIF) 48 hours after infection. Alternatively, the infected cells were passaged on inactivated C3H feeders and next day induced with Dox. The number of GFP^+^ colonies were counted 1 and 2 weeks after Dox induction. Dox was removed after 12 days of induction (2 days before the second evaluation) to count only transgene-independent iPSC colonies.

For the RNAi experiment, OG2 MEFs were infected with pLKO.puro shRNA viruses and selected with (8 μg/ml) puromycin. After 48 hours, the cells were split and infected with rtTA and tetO-OSKM or tetO-SKM viruses as described above. The selection with (4 μg/ml) puromycin was continued during the whole reprogramming experiment to eliminate the cells that silence shRNA transgenes. Statistical significance was calculated using Student's t test.

For episomal reprogramming MEFs were plated on 6-well plates (10^5^ per well) and transfected with 2 μg of pCXLE-KSM, or 1 μg of pCXLE-KSM and 1 μg of pCXLE-Oct4 using Fugene 6 (Roche). The transfection was repeated after 48h; the medium was changed to ESC medium after another 48h. Only GFP^+^ epiKSMO iPSCs that appeared within 1 week were picked to avoid epiKSM iPSCs.

### Characterization of iPSCs {#sec4.4.6}

For immunostaining, the cells were fixed with 4% PFA, permeabilized, and stained for stage-specific embryonic antigen 1 (SSEA-1, Millipore, MC-480, 1:200), Nanog (eBioscience, eBioMLC-51, 1:1000), Oct4 (Santa Cruz, N-19, sc-8628, 1:500) and Sall4 (Santa Cruz, EE-30, sc-101147, 1:500). Naphtol and fast red were used for alkaline phosphatase (AP) staining.

For bisulfate genomic sequencing, 1 μg of genomic DNA was bisulfate converted using EZ DNA methylation kit (Zymo Research) according to the manufacturer's protocol. The promoter regions of *Oct4*, *Nanog*, and *Col1a1* were PCR amplified using HotStart Taq (QIAGEN) using primers listed in [Table S3](#mmc1){ref-type="supplementary-material"}. The PCR products were cloned using TOPO-TA kit (Invitrogen) and sequenced. The data were plotted using QUMA.

Combined bisulphite restriction analysis (COBRA) was used to determine DNA methylation status at imprinting loci. Bisulfite conversion was carried out on 2 ug of isolated genomic DNA using the EZ DNA methylation kit (Zymo research) according to the manufacturer's protocol. The bisulfite converted DNA was amplified by PCR with primers previously described ([@bib90]). PCR products were then purified using the Nucleospin gel and PCR clean-up (MACHEREY-NAGEL) according to the manufacturer's protocol. The purified PCR products were digested with appropriated restriction enzymes, and digested patterns were analyzed on 3% agarose gel.

To make chimera embryos, 8-cell embryos were flushed from (C57BL/6 x C3H) F1 females x CD1 males at 2.5 days postcoitum (dpc) and placed in M2 medium ([@bib27]). 8 to 10 trypsinized iPSC cells were transferred into microdrops of potassium simplex optimized medium (KSOM) under mineral oil; each clump was placed in a depression in the microdrop. Meanwhile, batches of 30-40 embryos were briefly incubated in acidified Tyrode's solution ([@bib27]) until dissolution of their zona pellucida. A single embryo was placed on the clump and cultured overnight at 37C, 5% CO~2~. After 24 hours of culture, chimeric embryos were transferred into 2.5-dpc pseudopregnant recipients for further development.

For the teratoma formation assay, 5 × 10^6^ cells were injected subcutaneously into the flank of SCID mice. After 4‒5 weeks, the teratoma that had developed was excised, fixed in 4% paraformaldehyde, and subjected to histological examination with H&E staining.

Tetraploid (4N) complementation was performed as described before ([@bib60]). Briefly, two-cell--stage embryos were fused with electrical pulses. The fused embryos (tetraploid, 4N) were cultured for 24 hr to the 4-cell stage and aggregated with fifteen trypsin-digested iPSCs. The aggregates were cultured at 37C, 5% CO2 for 24 h and subsequently transferred into one uterine horn of a 2.5 dpc pseudopregnant recipient CD-1 mice for full term development.

Mice were housed in the animal facility of the Max Planck Institute for Molecular Biomedicine in Münster in compliance with the GV-SOLAS guidelines and all animal experiments were approved by the State Office for Nature, Environment and Consumer Protection North Rhine-Westphalia (LANUV).

### RNA-sequencing and data analysis {#sec4.4.7}

Time-course reprogramming RNA-seq was done for two biological replicates of every condition. ESC and iPSC lines were passaged twice in 2iL medium without feeders for RNA isolation. For embryo sequencing, three E9.5 embryos from at least two independent pregnancies were used for each iPSC lines. The embryos of abnormal size or appearance were discarded. Control embryos were trypsinised and FACS-sored similarly to 4N complementation-derived embryos. NEBNExt ultra Directional RNA Kit with polyA enrichment was used for library preparation. Sequencing was done by HiSeq 3000/4000 (Illumina) with paired-end 75bp or single end 150 bp reads. Reads were aligned to the mm10 reference genome using CLC Genomics Workbench 11.0. DESeq2 R package were used for the differential expression analysis. mFUZZ package was used for time-course gene clustering ([@bib35]). Gplots and pheatmap R packages were used for plotting the histograms.

### Generating Oct4 knockout fibroblasts {#sec4.4.8}

For Oct4 conditional knockout, male Acr-EGFP ESCs ([@bib1]) were targeted with the construct containing floxed Pou5f1 exon 2-5 together with a FRT-IRES-βgeo-pA cassette and transiently transfected with a FLPe expression vector to remove the FRT cassette. Chimeric mice were generated by aggregation of *Oct4*^*WT/flox*^ ESCs with zona pellucida-free eight-cell-stage embryos. *Oct4flox/flox; Rosa26-CreERT2* MEFs were conditionally immortalized with lentiviral dox-inducible SV40LT and simultaneously treated with tamoxifen. The clonal lines were genotyped with a mix of following primers: forward 5′-GCTCCAACAACCTGCTCCTCTTCCGCC-3′, 5′-GGATGCTGTGAGCCAAGG-3′, and reverse 5′-GCTTTCTCCAACCGCAGGCTCTCT-3′.

Data and Code Availability {#sec4.5}
--------------------------

RNA-seq data are available from Gene Expression Omnibus under accession number GEO: [GSE137001](ncbi-geo:GSE137001){#intref0105}.

Supporting Citations {#app3}
====================

The following references appear in the Supplemental Information: [@bib18], [@bib20], [@bib22], [@bib28], [@bib31], [@bib57], [@bib76], [@bib78].

Supplemental Information {#app2}
========================

Document S1. Figures S1--S7 and Tables S1--S3Document S2. Article plus Supplemental Information

We thank Konrad Hochedlinger for providing the tetO-BKSM and tetO-OKSM constructs and Konstantinos Anastassiadis for the Bluescript-SV40LT vector. We are grateful to Martina Sinn for histology, Ingrid Gelker and Maryna Samus for cell culture, Martin Stehling for FACS, Dagmar Zeuschner for electron microscopy, Dong Han for providing *Oct4* ^*flox/flox*^ MEFs, and Jonghun Kim and Dong Wook Han for G-band karyotyping. We also thank Janina Fuss, Kurt Stüber, and Anika Witten for RNA-seq; Areti Malapetsas for editing the manuscript; and Oleksandr Dovgusha, Clemens Hug, Eva Kutejova, and Joschka Hey for providing the scripts for RNA-seq analysis. The work was funded by the Max Planck Society and the Max Planck Center grant, as well as the ERC (advanced grant proposal 669168).

Author Contributions {#sec5}
====================

S.V. and H.R.S. conceived the study. S.V. performed most of the experiments; assembled, analyzed, and interpreted data; and wrote the manuscript. K.A. and G.W. generated *Oct4*^*flox/flox*^ mouse. K.A. advised on the project and analyzed published ChIP-seq data. K.-P.K. performed DNA methylation assays. Y.H. performed qPCRs. C.M.M. wrote the manuscript. G.W. performed all the mouse experiments, generated ESC lines, and assembled and interpreted the data. H.R.S. supervised the project, interpreted data, and wrote the manuscript.

Declaration of Interests {#sec6}
========================

The authors declare no competing interests.

Supplemental Information can be found online at <https://doi.org/10.1016/j.stem.2019.10.002>.

[^1]: Lead Contact
